The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

NCT01148537 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Buprenorphine transdermal patch
DRUG: Matching placebo transdermal patch
DRUG: Avelox (moxifloxacin hydrochloride) tablet

Sponsor

Purdue Pharma LP